By Dr Nikola Mitrev

Conference Papers

An YK; Lindsay N; Allan N; Khoo E; Fernandes R; Amiss A; Pham H; Wong KF; Ooi SY; Thin L; Lightowler D; Connor SJ; Williams AJ; De Cruz P; Suen CLW; Kariyawasam V; Mitrev N; Ghaly S; Andrews JM; Christensen B; Sparrow MP; White LS; Bryant RV; Ding N; Leong R; Van Langenberg D; Seltenreich H; Subramaniam K; Radford-Smith G; Begun J, 2023, 'Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn's disease patients: results from the AURORA Study including ANZIBDC Cohort', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. 793 - 794, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601372&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Karimi N; Lukin A; Moore AR; Pipicella J; Kanazaki R; Williams A-J; Ng W; Kariyawasam V; Mitrev N; Pandya K; Connor S, 2023, 'Talking with emerging adults living with inflammatory bowel disease: A qualitative study of clinical communication in gastroenterology', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 175 - 176

An Y-K; Lindsay N; Allan N; Khoo E; Amiss A; Moniruzzaman M; Fernandes R; Ooi S-Y; Thin L; Lightowler D; Connor S; Williams A-J; De Cruz P; Suen CLW; Kariyawasam V; Mitrev N; Ghaly S; Andrews JM; Christensen B; Sparrow M; White L; Bryant RV; Ding N; Leong R; Van Langenberg D; Seltenreich H; Subramaniam K; Radford-Smith G; Begun J, 2022, 'Post-induction IL-12/23 levels correlate with clinical response and remission after ustekinumab in a multicenter prospective cohort study of patients with Crohn's disease: Preliminary induction results of the AURORA study, including the Australia New Zealand IBD Consortium Cohort', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 146 - 147, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mitrev N; Nasr M; Segboer H; Corte C; Liu K, 2020, 'PREVALENCE AND IMPACT OF FRAILTY AMONG INFLAMMATORY BOWEL DISEASE OUTPATIENTS', in GUT, BMJ PUBLISHING GROUP, pp. A55 - A55, http://dx.doi.org/10.1136/gutjnl-2020-IDDF.102

Nasr M; Segboer H; Mitrev N; Corte C; Liu K, 2020, 'Prevalence, risk factors, and impact of frailty among outpatients with inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 123 - 123, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mitrev N; Vande Casteele N; Seow C; Andrews JM; Connor SJ; Moore G; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; Van Langenberg D; Ward MG; Leong RW, 2017, 'Therapeutic drug monitoring-guided biological drug therapy in inflammatory bowel disease: Consensus statements of the Australian Inflammatory Bowel Disease Association (AIBDA) and Gastroenterological Society of Australia (GESA)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 136 - 138, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100247&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Leong RW; Mitrev N; Ko Y, 2016, 'Hygiene Hypothesis: Is the Evidence the Same All over the World?', in Digestive Diseases, pp. 35 - 42, http://dx.doi.org/10.1159/000442922

Back to profile page